News Publications January 13, 2023 APOE3 Christchurch modulates tau phosphorylation and β-catenin/Wnt/Cadherin signaling in induced pluripotent stem cell-derived cerebral organoids from Alzheimer’s cases (bioRxiv) July 15, 2022 Distinct tau neuropathology and cellular profiles of an APOE3 Christchurch homozygote protected against autosomal dominant Alzheimer’s dementia (Acta Neuropathologica) November 4, 2019 Resistance to autosomal dominant Alzheimer’s disease in an APOE3 Christchurch homozygote: a case report (Nature Medicine) May 1, 2018 Association Between Amyloid and Tau Accumulation in Young Adults With Autosomal Dominant Alzheimer Disease (JAMA Neurology) Press December 11, 2020 In Life, She Defied Alzheimer’s. In Death, Her Brain May Show How (New York Times) November 4, 2019 Why Didn’t She Get Alzheimer’s? The Answer Could Hold a Key to Fighting the Disease (New York Times)